GuidanceMHRA
Guidelines for submitting a nutritional product to the ACBS
Information and advice on submitting a nutritional product to the Advisory Committee for Borderline Substances (ACBS).
First published: Apr 11, 2019Last updated: Feb 1, 2024Changes: 8
Latest change: Removed 'Appendix 2.1: evidence required for type 3 applications' because this document no longer applies.
The full document, source attachments, and change history are available on KeyPedia. Sign in to view.